Covid-19 pandemic has created roller-coaster situations for Pharma and MedTech companies.
For post-covid commercial restart, life science companies need to prepare for right sizing, not downsizing.
It could mean different setup, new capabilities, or move to omni-channel.
BlueJet Consulting can help !
Continue reading